Th1, Th2 and Th17 Cytokine Profile in Patients with Multiple Sclerosis Following Treatment with Rapamycin

Th1, Th2 and Th17 Cytokine Profile in Patients with Multiple Sclerosis Following Treatment with Rapamycin

<strong>Background</strong>: Management of multiple sclerosis (MS) is based on the usage of immunosuppressive and immune-modulating medications. Cytokines play an important role in the pathogenesis of MS. <br/><strong>Objective</strong>: To evaluate the effects of rapam...

Full description

Bibliographic Details
Main Authors: Mansour Salehi, Bahram Bagherpour, Vahid Shayghannejad, Farzaneh Mohebi, Rasool Jafari
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2016-06-01
Series:Iranian Journal of Immunology
Subjects:
Cytokine Profile
Multiple Sclerosis
Rapamycin
Online Access:http://iji.sums.ac.ir/article_16665_f83547dab1399dc9fa70a5c78f7fa04a.pdf

Internet

http://iji.sums.ac.ir/article_16665_f83547dab1399dc9fa70a5c78f7fa04a.pdf

Similar Items